NCT04982809View on ClinicalTrials.gov

Cost-effectiveness Analysis of Three Corticosteroids in ILDs

NACompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

March 15, 2020

Study Completion Date

March 15, 2020

Conditions
Interstitial Lung Disease
Interventions
DRUG

Betamethasone, Dexamethasone, Prednisolone

Corticosteroids

Trial Locations (1)

12411

Faculty of Pharmacy Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT04982809 - Cost-effectiveness Analysis of Three Corticosteroids in ILDs | Biotech Hunter | Biotech Hunter